GB9714081D0 - Pharmaceutical compositions - Google Patents

Pharmaceutical compositions

Info

Publication number
GB9714081D0
GB9714081D0 GBGB9714081.8A GB9714081A GB9714081D0 GB 9714081 D0 GB9714081 D0 GB 9714081D0 GB 9714081 A GB9714081 A GB 9714081A GB 9714081 D0 GB9714081 D0 GB 9714081D0
Authority
GB
United Kingdom
Prior art keywords
pharmaceutical compositions
pharmaceutical
compositions
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
GBGB9714081.8A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pfizer Ltd
Original Assignee
Pfizer Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Ltd filed Critical Pfizer Ltd
Priority to GBGB9714081.8A priority Critical patent/GB9714081D0/en
Priority to GBGB9718270.3A priority patent/GB9718270D0/en
Publication of GB9714081D0 publication Critical patent/GB9714081D0/en
Priority to UA99126573A priority patent/UA49955C2/uk
Priority to HN1998000101A priority patent/HN1998000101A/es
Priority to MYPI98002961A priority patent/MY119643A/en
Priority to PE1998000581A priority patent/PE84499A1/es
Priority to TR1999/03332T priority patent/TR199903332T2/xx
Priority to DZ980159A priority patent/DZ2549A1/xx
Priority to TNTNSN98126A priority patent/TNSN98126A1/fr
Priority to SI9830068T priority patent/SI0999841T1/xx
Priority to MA25150A priority patent/MA26518A1/fr
Priority to BR9810658-9A priority patent/BR9810658A/pt
Priority to ES98940152T priority patent/ES2163291T3/es
Priority to SK1828-99A priority patent/SK284462B6/sk
Priority to AU88569/98A priority patent/AU724728B2/en
Priority to DE69802097T priority patent/DE69802097T2/de
Priority to KR10-1999-7012523A priority patent/KR100384346B1/ko
Priority to NZ501419A priority patent/NZ501419A/xx
Priority to UY25078A priority patent/UY25078A1/es
Priority to PCT/EP1998/004176 priority patent/WO1999001135A1/en
Priority to IL13320698A priority patent/IL133206A0/xx
Priority to EA199901100A priority patent/EA002174B1/ru
Priority to DK98940152T priority patent/DK0999841T3/da
Priority to US09/402,239 priority patent/US6166025A/en
Priority to IDW991585A priority patent/ID24528A/id
Priority to PL98337803A priority patent/PL337803A1/xx
Priority to EP98940152A priority patent/EP0999841B1/en
Priority to AT98940152T priority patent/ATE206921T1/de
Priority to PA19988454501A priority patent/PA8454501A1/es
Priority to CA002292673A priority patent/CA2292673C/en
Priority to HU0004468A priority patent/HUP0004468A3/hu
Priority to PT98940152T priority patent/PT999841E/pt
Priority to CNB988066289A priority patent/CN1145486C/zh
Priority to JP50638199A priority patent/JP3350061B2/ja
Priority to ARP980103209A priority patent/AR013165A1/es
Priority to APAP/P/1998/001290A priority patent/AP1100A/en
Priority to ZA9805812A priority patent/ZA985812B/xx
Priority to CO98037816A priority patent/CO4950555A1/es
Priority to GT199800105A priority patent/GT199800105A/es
Priority to IS5283A priority patent/IS5283A/is
Priority to BG103930A priority patent/BG103930A/xx
Priority to NO19995887A priority patent/NO312993B1/no
Priority to OA9900271A priority patent/OA11227A/en
Priority to HR970276A priority patent/HRP990416B1/xx
Priority to HK01100144A priority patent/HK1029282A1/xx
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52—Purines, e.g. adenine
    • A61K31/522—Purines, e.g. adenine having oxo groups directly attached to the heterocyclic ring, e.g. hypoxanthine, guanine, acyclovir
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52—Purines, e.g. adenine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404—Indoles, e.g. pindolol

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Packaging Of Annular Or Rod-Shaped Articles, Wearing Apparel, Cassettes, Or The Like (AREA)
  • Medicines Containing Plant Substances (AREA)
GBGB9714081.8A 1997-07-03 1997-07-03 Pharmaceutical compositions Pending GB9714081D0 (en)

Priority Applications (45)

Application Number Priority Date Filing Date Title
GBGB9714081.8A GB9714081D0 (en) 1997-07-03 1997-07-03 Pharmaceutical compositions
GBGB9718270.3A GB9718270D0 (en) 1997-07-03 1997-08-28 Pharmaceutical compositions
UA99126573A UA49955C2 (uk) 1997-07-03 1998-01-07 Водна фармацевтична композиція, що містить гемісульфат елетриптану і кофеїн
HN1998000101A HN1998000101A (es) 1997-07-03 1998-06-30 Corte de hojas para armar cajetillas de cigarrillos
MYPI98002961A MY119643A (en) 1997-07-03 1998-06-30 Pharmaceutical compositions containing eletriptan hemisulphate and caffeine
PE1998000581A PE84499A1 (es) 1997-07-03 1998-06-30 Composiciones farmaceuticas que contienen eletriptan hemisulfato
ARP980103209A AR013165A1 (es) 1997-07-03 1998-07-01 Composiciones farmaceuticas que contienen eletriptan hemisulfato
DK98940152T DK0999841T3 (da) 1997-07-03 1998-07-01 Farmaceutiske præparater indeholdende eletriptanhemisulfat og koffein
PL98337803A PL337803A1 (en) 1997-07-03 1998-07-01 Pharmaceutic agents containing eletriptane hemisulphate and caffeine
TNTNSN98126A TNSN98126A1 (fr) 1997-07-03 1998-07-01 Compositions pharmaceutiques contenant de l'hemisulfate d'eletriptan
SI9830068T SI0999841T1 (ko) 1997-07-03 1998-07-01
MA25150A MA26518A1 (fr) 1997-07-03 1998-07-01 Compositions pharmaceutiques contenant de l'hemisulfate d'eletriptan
BR9810658-9A BR9810658A (pt) 1997-07-03 1998-07-01 Composições farmacêuticas contendo hemissulfato de eletriptano e cafeìna.
ES98940152T ES2163291T3 (es) 1997-07-03 1998-07-01 Composiciones farmaceuticas que contienen eletriptan hemisulfato y cafeina.
SK1828-99A SK284462B6 (sk) 1997-07-03 1998-07-01 Vodná farmaceutická kompozícia obsahujúca eletriptan hemisulfát a jej použitie
AU88569/98A AU724728B2 (en) 1997-07-03 1998-07-01 Pharmaceutical compositions containing eletriptan hemisulphate and caffeine
DE69802097T DE69802097T2 (de) 1997-07-03 1998-07-01 Eletriptanhemisulfat und kaffein enthaltende pharmazeutische zusammenstellungen
KR10-1999-7012523A KR100384346B1 (ko) 1997-07-03 1998-07-01 엘레트립탄 헤미술페이트 및 카페인을 포함하는 약제학적조성물
NZ501419A NZ501419A (en) 1997-07-03 1998-07-01 Pharmaceutical compositions containing eletriptan hemisulphate and caffeine for treating migraines, depression and eating disorders
UY25078A UY25078A1 (es) 1997-07-03 1998-07-01 Composiciones farmacéuticas que contienen eletriptan hemisulfato estabilizadas con cafeína
PCT/EP1998/004176 WO1999001135A1 (en) 1997-07-03 1998-07-01 Pharmaceutical compositions containing eletriptan hemisulphate and caffeine
IL13320698A IL133206A0 (en) 1997-07-03 1998-07-01 Pharmaceutical compositions containing eletriptan hemisulphate and caffeine
EA199901100A EA002174B1 (ru) 1997-07-03 1998-07-01 Фармацевтические композиции, содержащие гемисульфат элетриптана и кофеин
TR1999/03332T TR199903332T2 (xx) 1997-07-03 1998-07-01 Eletriptan hemis�lfat ve kafein i�eren farmas�tikal bile�ikler.
US09/402,239 US6166025A (en) 1997-07-03 1998-07-01 Pharmaceutical compositions containing eletriptran hemisulphate and caffeine
IDW991585A ID24528A (id) 1997-07-03 1998-07-01 Komposisi-komposisi obat farmasi yang mengandung eletriptan hemisulfat dan kafein
DZ980159A DZ2549A1 (fr) 1997-07-03 1998-07-01 Compositions pharmaceutiques contenant de l'hémisulfate d'élétriptan.
EP98940152A EP0999841B1 (en) 1997-07-03 1998-07-01 Pharmaceutical compositions containing eletriptan hemisulphate and caffeine
AT98940152T ATE206921T1 (de) 1997-07-03 1998-07-01 Eletriptanhemisulfat und kaffein enthaltende pharmazeutische zusammenstellungen
PA19988454501A PA8454501A1 (es) 1997-07-03 1998-07-01 Composiciones farmaceuticas que contienen eletriptan hemisulfato
CA002292673A CA2292673C (en) 1997-07-03 1998-07-01 Pharmaceutical compositions containing eletriptan hemisulphate
HU0004468A HUP0004468A3 (en) 1997-07-03 1998-07-01 Pharmaceutical compositions containing eletriptan hemisulphate and caffeine
PT98940152T PT999841E (pt) 1997-07-03 1998-07-01 Composicoes farmaceuticas contendo hemissulfato de eletriptano
CNB988066289A CN1145486C (zh) 1997-07-03 1998-07-01 含eletriptan半硫酸盐和咖啡因的药用组合物
JP50638199A JP3350061B2 (ja) 1997-07-03 1998-07-01 エレトリプタンヘミスルフェートおよびカフェインを含有する医薬組成物
ZA9805812A ZA985812B (en) 1997-07-03 1998-07-02 Pharmaceutical compositions containing eletriptan hemisulphate.
APAP/P/1998/001290A AP1100A (en) 1997-07-03 1998-07-02 Pharaceutical compositions containing eletriptan hemisulphate.
CO98037816A CO4950555A1 (es) 1997-07-03 1998-07-03 Composiciones farmaceuticas que contienen eleptriptan hemisulfato
GT199800105A GT199800105A (es) 1997-07-03 1998-07-13 Composiciones farmaceuticas que contienen eletriptan hemisulfato.
IS5283A IS5283A (is) 1997-07-03 1999-11-30 Lyfjasamsetningar sem innihalda eletriptan hemisúlfat og koffín
BG103930A BG103930A (en) 1997-07-03 1999-11-30 Eletriptan hemisulphate and caffeine containing pharmaceutical compositions
NO19995887A NO312993B1 (no) 1997-07-03 1999-12-01 Farmasöytiske blandinger inneholdende eletripanhemisulfat og koffein, anvendelse derav som medikament og for fremstilling av etmedikament
OA9900271A OA11227A (en) 1997-07-03 1999-12-03 Pharmaceutical compositions containing eletriptan hemisulphate and caffeine
HR970276A HRP990416B1 (en) 1997-07-03 1999-12-30 Pharmaceutical compositions containing eletriptan hemisulphate and caffeine
HK01100144A HK1029282A1 (en) 1997-07-03 2001-01-05 Pharmaceutical compositions containing eletriptan hemisulphate and caffeine.

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9714081.8A GB9714081D0 (en) 1997-07-03 1997-07-03 Pharmaceutical compositions

Publications (1)

Publication Number Publication Date
GB9714081D0 true GB9714081D0 (en) 1997-09-10

Family

ID=10815339

Family Applications (2)

Application Number Title Priority Date Filing Date
GBGB9714081.8A Pending GB9714081D0 (en) 1997-07-03 1997-07-03 Pharmaceutical compositions
GBGB9718270.3A Pending GB9718270D0 (en) 1997-07-03 1997-08-28 Pharmaceutical compositions

Family Applications After (1)

Application Number Title Priority Date Filing Date
GBGB9718270.3A Pending GB9718270D0 (en) 1997-07-03 1997-08-28 Pharmaceutical compositions

Country Status (13)

Country Link
KR (1) KR100384346B1 (ko)
AP (1) AP1100A (ko)
AR (1) AR013165A1 (ko)
CO (1) CO4950555A1 (ko)
GB (2) GB9714081D0 (ko)
GT (1) GT199800105A (ko)
HN (1) HN1998000101A (ko)
MY (1) MY119643A (ko)
PA (1) PA8454501A1 (ko)
PE (1) PE84499A1 (ko)
TN (1) TNSN98126A1 (ko)
UA (1) UA49955C2 (ko)
ZA (1) ZA985812B (ko)

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9417310D0 (en) * 1994-08-27 1994-10-19 Pfizer Ltd Therapeutic agents

Also Published As

Publication number Publication date
AR013165A1 (es) 2000-12-13
ZA985812B (en) 2000-01-10
HN1998000101A (es) 1999-01-08
CO4950555A1 (es) 2000-09-01
TNSN98126A1 (fr) 2005-03-15
GB9718270D0 (en) 1997-11-05
AP9801290A0 (en) 1998-09-30
KR100384346B1 (ko) 2003-05-16
MY119643A (en) 2005-06-30
PE84499A1 (es) 1999-09-11
PA8454501A1 (es) 2000-05-24
UA49955C2 (uk) 2002-10-15
KR20010014366A (ko) 2001-02-26
GT199800105A (es) 2000-01-04
AP1100A (en) 2002-09-02

Similar Documents

Publication Publication Date Title
GB9727053D0 (en) Pharmaceutical compositions
EG24118A (en) Pharmaceutical compositions
GB9706089D0 (en) Pharmaceutical composition
CY2569B1 (en) Pharmaceutical compositions
GB9616672D0 (en) Pharmaceutical compositions
GB9610359D0 (en) Pharmaceutical compositions
GB9717444D0 (en) Pharmaceutical composition
IL131995A0 (en) Gastric-retained pharmaceutical compositions
GB9723985D0 (en) Pharmaceutical compositions
GB9717428D0 (en) Pharmaceutical composition
ZA9811532B (en) Pharmaceutical compositions
GB9622681D0 (en) Pharmaceutical compositions
GB9606429D0 (en) Pharmaceutical compositions
HU9700632D0 (en) Pharmaceutical compositions
GB9613457D0 (en) Pharmaceutical compositions
GB9618376D0 (en) Pharmaceutical compositions
GB9717770D0 (en) Pharmaceutical composition
GB9610136D0 (en) Pharmaceutical compositions
ZA982117B (en) Pharmaceutical compositions
GB2321190B (en) Pharmaceutical composition
GB9726781D0 (en) Pharmaceutical composition
GB9710527D0 (en) Pharmaceutical compositions
GB9718270D0 (en) Pharmaceutical compositions
GB9714328D0 (en) Pharmaceutical compositions
GB9710505D0 (en) Pharmaceutical compositions